Aqueous coating compositions
US-9221992-B2 · Dec 29, 2015 · US
US9416210B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9416210-B2 |
| Application number | US-200913131665-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 11, 2009 |
| Priority date | Dec 12, 2008 |
| Publication date | Aug 16, 2016 |
| Grant date | Aug 16, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention generally relates to zwitterionic polymers (including zwitterionic copolymers), such as polymethacrylic structures, with pendent functional moieties, such as therapeutic or biologic moieties. More particularly, the invention relates to phosphorylcholine-substituted methacrylic polymers prepared by free radical polymerization and click chemistry, for example, and compositions and products comprising same, as well as related methods and uses of the compositions, for example, as biological or therapeutic agents and in drug delivery thereof.
Opening claim text (preview).
What is claimed is: 1. A co-polymer comprising the structure of: wherein each of R 1 and R 3 is independently a hydrogen, alkyl, or halogen; each of R 2 and R 4 is independently a hydrogen, (C 1 -C 15 ) alkyl, (C 1 -C 15 ) alkyloxy, or halogen; R Z is a group comprising a zwitterionic moiety; m is an integer from 1 to about 500; n is an integer from 1 to about 100; L q is a linking group; R X is a group comprising an azide or a carbon-carbon triple bond; L T is a linking group; T is a targeting moiety towards a biological target; and wherein T is selected from the group consisting of an antibody, protein, aptamer, or a small molecule comprising a folate moiety. 2. The co-polymer of claim 1 , wherein, L T comprises an amide moiety. 3. The co-polymer of claim 1 , wherein the co-polymer has a M n from about 5 kDa to about 100 kDa. 4. The polymer of claim 1 , wherein the polymer is crosslinked. 5. The polymer of claim 1 , wherein the polymer is a block-copolymer.
condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines (yohimbine derivatives, vinblastine A61K31/475; ergoline derivatives A61K31/48) · CPC title
Copolymers of compounds having one or more carbon-to-carbon triple bonds · CPC title
attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin {(digitoxin A61K31/7048)} · CPC title
Introducing nitrogen atoms or nitrogen-containing groups · CPC title
using free radical "living" or "controlled" polymerisation, e.g. using a complexing agent · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.